6,377
Views
10
CrossRef citations to date
0
Altmetric
Review

Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis

Pages 691-701 | Received 17 Feb 2022, Accepted 24 May 2022, Published online: 23 Jun 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.